Literature DB >> 19487052

[Validity of the MONICA cardiovascular questionnaire compared with clinical records].

José M Baena-Díez1, María T Alzamora-Sas, María Grau, Isaac Subirana, Joan Vila, Pere Torán, Ylenia García-Navarro, Noemí Bermúdez-Chillida, Judit Alegre-Basagaña, María Viozquez-Meia, Jaume Marrugat.   

Abstract

OBJECTIVE: To assess the validity of the questionnaire Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) compared with clinical records.
METHODS: A descriptive, prospective, multicenter study was performed within the framework of the Peripheral Arterial Disease Study (PERART) in 3,329 persons aged >50 years old. The sample was selected by simple random sampling in 32 primary health care centers. The diagnoses included were acute myocardial infarction, angina pectoris, cerebrovascular disease, hypertension, diabetes mellitus, and hypercholesterolemia. Treatment variables were also considered (antihypertensive, lipid-lowering and hypoglycemic agents or insulin, as well as antiplatelet or anticoagulant agents). The sensitivity, specificity, predictive values, and kappa index were computed to test the validity of the MONICA questionnaire.
RESULTS: The mean age was 65 years (SD 8.9) and 54.8% were women. The sensitivity of the questionnaire was >90% for all the variables apart from angina pectoris (89.9%) and cerebrovascular disease (86.5%). Specificity was also >90%, except for angina pectoris (88.3%) and hypercholesterolemia (77.5%). The positive predictive value was >90% for all the treatments; >80% for angina pectoris, acute myocardial infarction and hypertension; 79.4% for cerebrovascular disease; 79.1% for hypercholesterolemia and 73.4% for diabetes mellitus. The negative predictive value was >90% for all the variables. The kappa indexes were >0.80 for all the variables apart from hypercholesterolemia (0.69) and diabetes mellitus (0.79).
CONCLUSIONS: The MONICA cardiovascular questionnaire is valid in the assessment of cardiovascular disease, risk factors and treatments in patients aged >50 years old.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487052     DOI: 10.1016/j.gaceta.2009.01.009

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  7 in total

1.  Cardiovascular risk factors, lifestyle, and social determinants: a cross-sectional population study.

Authors:  Luis Palomo; Francisco-Javier Félix-Redondo; Luis Lozano-Mera; José-Fernando Pérez-Castán; Daniel Fernández-Berges; Francisco Buitrago
Journal:  Br J Gen Pract       Date:  2014-10       Impact factor: 5.386

2.  [Prevalence, awareness, treatment and control of cardiovascular risk factors in the Extremadura population (Spain). HERMEX study].

Authors:  Francisco Javier Félix-Redondo; Daniel Fernández-Bergés; José Fernando Pérez; María José Zaro; Antonio García; Luis Lozano; Héctor Sanz; María Grau; Paula Alvarez-Palacios; Verónica Tejero
Journal:  Aten Primaria       Date:  2011-02-24       Impact factor: 1.137

3.  Unfavourable life-course social gradient of coronary heart disease within Spain: a low-incidence welfare-state country.

Authors:  Lluís Cirera; José María Huerta; María Dolores Chirlaque; Genevieve Buckland; Nerea Larrañaga; María José Sánchez; Antonio Agudo; Pilar Amiano; José Ramón Quirós; Eva Ardanaz; Larraitz Arriola; Esther Molina; Miren Dorronsoro; Aurelio Barricarte; Carlos A González; Concepción Moreno-Iribas; Carmen Navarro
Journal:  Int J Public Health       Date:  2012-06-07       Impact factor: 3.380

4.  Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity.

Authors:  Concepción Violán; Quintí Foguet-Boreu; Eduardo Hermosilla-Pérez; Jose M Valderas; Bonaventura Bolíbar; Mireia Fàbregas-Escurriola; Pilar Brugulat-Guiteras; Miguel Ángel Muñoz-Pérez
Journal:  BMC Public Health       Date:  2013-03-21       Impact factor: 3.295

5.  Impact of a partial smoke-free legislation on myocardial infarction incidence, mortality and case-fatality in a population-based registry: the REGICOR Study.

Authors:  Fernando Agüero; Irene R Dégano; Isaac Subirana; Maria Grau; Alberto Zamora; Joan Sala; Rafel Ramos; Ricard Treserras; Jaume Marrugat; Roberto Elosua
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

6.  Cognitive impairment and dependence of patients with diabetes older than 65 years old in an urban area (DERIVA study).

Authors:  Emiliano Rodríguez-Sánchez; Sara Mora-Simón; María C Patino-Alonso; Diana Pérez-Arechaederra; José I Recio-Rodríguez; Manuel A Gómez-Marcos; Luis F Valero-Juan; Luis García-Ortiz
Journal:  BMC Geriatr       Date:  2016-02-01       Impact factor: 3.921

7.  Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).

Authors:  Cheryl Vigen; Marilyn L Kwan; Esther M John; Scarlett Lin Gomez; Theresa H M Keegan; Yani Lu; Salma Shariff-Marco; Kristine R Monroe; Allison W Kurian; Iona Cheng; Bette J Caan; Valerie S Lee; Janise M Roh; Leslie Bernstein; Richard Sposto; Anna H Wu
Journal:  Cancer Causes Control       Date:  2016-01-21       Impact factor: 2.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.